New Opportunities for Cell Therapy Combinations

In this podcast moderated by Dr Michael Kalos, Janssen Oncology, you will hear a panel discussion from the 2019 IO Combinations 360° conference. Topic points include:

• What are the new opportunities in cell therapy for combinations?
• What the challenges are going to be with the microenvironment?
• What is being done to engineer cell therapy?
• How do you develop CARs and TCRs that deliver payloads?
• How do you manufacture all of this beyond mouse models to
  figure out how to effectively do this in patients?
• How do you actually go about designing trials and testing
  hypothesis?
• How do you create the regulatory framework to do these types
  of studies?
• How do you engage with regulatory agencies to get these things
  moving?

Panelists include:

• Sharon Benzeno, PhD, MBA, Adaptive Biotechnologies
• Chaohong Fan, MD, PhD, FDA
• Bruce Levine, PhD, University of Pennsylvania
• Mark Stewart, PhD, Friends of Cancer Research
• Bahram Valamehr, PhD, Fate Therapeutics

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com